npj Metabolic Health and Disease,
Journal Year:
2024,
Volume and Issue:
2(1)
Published: Oct. 11, 2024
Cardiometabolic
complications
of
obesity
present
a
growing
public
health
concern
and
are
associated
with
poor
outcomes,
mediated
in
part
by
an
increased
risk
for
cardiovascular
disease,
metabolic
dysfunction-associated
fatty
liver
systemic
insulin
resistance.
Recent
studies
support
that
both
resistance
also
aberrant
brain
metabolism
cognitive
impairment
similar
to
what
is
observed
neurodegenerative
diseases.
Central
these
pathological
outcomes
adverse
changes
tissue
glucose
ketone
body
metabolism,
suggesting
regulation
substrate
utilization
could
be
mechanistic
link
between
the
cardiometabolic
progression
decline.
Here,
we
review
physiological
conditions
emphasis
on
therapeutic
potential
bodies
treating
diseases
lead
We
highlight
recent
findings
associations
among
while
providing
theoretical
framework
which
may
promote
positive
preserve
function.
Lipids in Health and Disease,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: April 22, 2024
Abstract
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
has
garnered
considerable
attention
globally.
Changing
lifestyles,
over-nutrition,
and
physical
inactivity
have
promoted
its
development.
MASLD
is
typically
accompanied
by
obesity
strongly
linked
to
metabolic
syndromes.
Given
that
prevalence
on
the
rise,
there
an
urgent
need
elucidate
pathogenesis.
Hepatic
lipid
accumulation
generally
triggers
lipotoxicity
induces
or
progress
steatohepatitis
(MASH)
mediating
endoplasmic
reticulum
stress,
oxidative
organelle
dysfunction,
ferroptosis.
Recently,
significant
been
directed
towards
exploring
role
of
gut
microbial
dysbiosis
in
development
MASLD,
offering
a
novel
therapeutic
target
for
MASLD.
Considering
are
no
recognized
pharmacological
therapies
due
diversity
mechanisms
involved
difficulty
associated
with
undertaking
clinical
trials,
potential
targets
remain
elusive.
Thus,
this
article
aimed
summarize
evaluate
prominent
roles
lipotoxicity,
ferroptosis,
microbes
underlying
their
effects.
Furthermore,
existing
advances
challenges
treatment
were
outlined.
Hepatology Communications,
Journal Year:
2024,
Volume and Issue:
8(7)
Published: July 1, 2024
With
an
increasing
prevalence,
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
has
become
a
major
global
health
problem.
MASLD
is
well-known
as
multifactorial
disease.
Mitochondrial
dysfunction
and
alterations
in
the
gut
bacteria
are
2
vital
events
MASLD.
Recent
studies
have
highlighted
cross-talk
between
microbiota
mitochondria,
mitochondria
recognized
pivotal
targets
of
to
modulate
host's
physiological
state.
plays
role
associated
with
multiple
pathological
changes,
including
hepatocyte
steatosis,
oxidative
stress,
inflammation,
fibrosis.
Metabolites
crucial
mediators
that
influence
extraintestinal
organs.
Additionally,
regulation
composition
may
serve
promising
therapeutic
strategy
for
This
study
reviewed
potential
roles
several
common
metabolites
MASLD,
emphasizing
their
impact
on
mitochondrial
function.
Finally,
we
discuss
current
treatments
probiotics,
prebiotics,
antibiotics,
fecal
transplantation.
These
methods
concentrate
restoring
promote
host
health.
Natural Product Communications,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: Jan. 1, 2025
Objective:
To
analyze
the
effective
ingredients
and
molecular
mechanisms
of
Shenling
Baizhu
powder
(SLBZP)
in
treatment
metabolic
associated
fatty
liver
disease
(MAFLD)
through
network
pharmacology
technology
experimental
validation.
Methods:
The
active
components
targets
SLBZP
were
obtained
from
TCMS
databases,
GeneCards,
TTD
DisGeNET
databases
used
to
predict
screen
for
MAFLD-related
genes.
An
“herb-active
components-crossover
targets”
was
constructed
using
Cytoscape3.7.2
software.
STRING11.5
applied
construction
PPI
network.
GO
KEGG
analysis
performed
investigate
biological
processes
pathways
involved
SLBZP.
Molecular
docking
AutoDock
Vina1.1.2
validate
binding
ability
between
compounds
core
crossover
targets.
Subsequently,
potential
mechanism
on
MAFLD
predicted
by
pharmacological
experimentally
studied
verified.
Results:
122
participated
41
identified
revealed
that
ALB,
TNF,
IL1B,
PPARα,
PPARγ,
HMOX1,
PTGS2,
IL6
ADIPOQ
number
common
263
process
items
42
signal
after
analysis.
main
target
protein
had
a
good
docking.
Through
results,
shown
be
ameliorating
lipid
accumulation
hepatic
steatosis
high-fat
diet-fed
rats
PA-induced
HepG2
cells
prevent
MAFLD.
And
results
cellular
experiments
suggest
may
improve
AMPK
signaling
pathway.
Conclusion:
effectively
ameliorates
MAFLD,
related
Natural Product Communications,
Journal Year:
2025,
Volume and Issue:
20(2)
Published: Feb. 1, 2025
Background
High-fat
diet
(HFD)-induced
nonalcoholic
fatty
liver
disease
(NAFLD)
is
a
key
link
between
several
medical
conditions
and
becoming
major
health
concern
affecting
thousands
of
people
globally.
Andrographolide,
an
active
ingredient
extracted
from
Andrographis
paniculate,
has
shown
anti-inflammatory
anti-fibrosis
effects
in
recent
studies.
Objective
This
study
aims
to
explore
whether
andrographolide
can
mitigate
HFD-induced
NAFLD
the
underlying
mechanism.
Methods
We
treated
C57B/6
mice
consuming
high-fat
(HFD)
with
varying
concentrations
andrographolide.
Enzyme-linked
immunosorbent
assay
(ELISA)
was
employed
evaluate
function
indicators
circulating
blood.
Haematoxylin
Eosin
Oil
Red
O
staining
were
used
assess
inflammation
infiltration
lipid
deposits
tissues.
Reverse
transcription-quantitative
polymerase
chain
reaction
(RT-qPCR)
immunoblotting
analyze
expression
levels
genes
proteins.
Results
ELISA
revealed
that
dose-dependently
mitigated
elevations
glucose,
alanine
aminotransferase,
aspartate
aminotransferase
Histological
analysis
indicated
reduced
deposition.
RT-qPCR
analyses
showed
inhibited
overproduction
tumor
necrosis
factor
(TNF)-α,
interleukin
(IL)-1β,
IL-6,
up-regulation
p-p65
NLRP3
Conclusion
Together,
these
results
suggest
treatment
impairments,
accumulation,
pro-inflammatory
cytokine
overproduction,
inflammatory
responses
by
regulating
NF-κB
signaling
pathway.
However,
it
important
note
our
are
observational
do
not
conclusively
demonstrate
necessity
pathway's
involvement
NAFLD-alleviating
highlights
need
for
further
validation
at
both
gene
protein
through
additional
vitro
vivo
experiments.
Natural Product Communications,
Journal Year:
2025,
Volume and Issue:
20(2)
Published: Feb. 1, 2025
Diabetic
nephropathy
(DN)
is
the
leading
cause
of
uremia
and
clinical
mortality,
characterized
by
progressive
deterioration
kidney
structure
function
due
to
prolonged
exposure
hyperglycemia.
This
condition
often
necessitates
renal
replacement
therapy
for
patients
with
end-stage-renal-disease
(ESRD).
Consequently,
early
detection,
diagnosis,
treatment
DN
are
crucial
mitigate
disease
progression,
enhance
patient
outcomes,
maintain
a
good
quality
life.
Exploring
relevant
biomarkers
diagnosis
holds
significant
importance.
In
recent
years,
numerous
researchers
have
identified
various
novel
associated
diabetic
nephropathy,
which
critical
predicting
both
onset
progression
disease.
article
aims
provide
comprehensive
overview
related
DN.
Journal of Biochemical and Molecular Toxicology,
Journal Year:
2025,
Volume and Issue:
39(3)
Published: Feb. 23, 2025
ABSTRACT
This
study
aimed
to
investigate
the
impact
of
in
vitro
low‐dose
arachidonic
acid
(AA)
addition
on
enhancing
sperm
motility
obese
infertile
men
with
asthenozoospermia.
Semen
samples
were
collected
from
115
men,
categorized
into
two
BMI
groups:
18.5–23.9
kg/m
2
and
≥
28
,
all
subjects
demonstrating
a
concentration
15
×
10
6
/mL.
These
further
divided
four
cohorts
based
percentage
progressive
(PR):
control‐normal,
control‐asthenozoospermia,
obese‐normal,
obese‐asthenozoospermia.
Normal
PR
was
classified
as
32%,
while
asthenozoospermia
characterized
by
<
32%.
Metabolomic
analysis
employed
quantify
seminal
plasma
metabolites,
differential
metabolites
identified
through
statistical
evaluation.
Additionally,
semen
men—5
body
mass
index
(BMI)
5
—underwent
scrutiny.
Post‐initial
analysis,
1
mL
stock
extracted,
treated
100
pg
AA,
incubated
at
37°C
for
h,
reanalyzed
determine
motility.
16
Sprague
Dawley
(SD)
rats
split
control
obese.
The
group
received
standard
diet,
subjected
45%
high‐fat
diet.
After
3
months,
euthanized
via
cervical
dislocation,
their
prostate
vesicles
metabolite
analysis.
A
comprehensive
4635
revealed
that
bile
secretion
emerged
most
significant
pathway
within
organic
systems
category,
accounting
0.6%
total
metabolites.
Meanwhile,
metabolic
pathways
overwhelmingly
dominated
metabolism
AA
contributing
4.62%.
Notably,
29
associated
secretion,
yet
no
differences
observed
between
32%
groups.
In
contrast,
214
linked
metabolism,
exhibiting
predominantly
downregulated
trend,
upregulated
identified.
Within
network,
indicators
showed
positive
association
induced
acrosome
reaction,
Ca
2+
levels,
PR,
proportion
grade
(rapid
forward
motion,
speed
25
μm/s).
secretory
phospholipase
A2
(sPLA2),
cyclooxygenase‐1
(COX1)
levels
demonstrated
negative
correlation
anthropometric
measurement
parameters
Control‐SP
group,
though
this
did
not
reach
significance,
evident
Obesity‐SP
group.
concentrations
sPLA2,
COX1
network
exhibited
following
trend:
Control‐SP‐N
>
Obesity‐SP‐N
Control‐SP‐A
Obesity‐SP‐A.
significantly
enhanced
B
(slow‐moving,
μm/s)
reducing
C
(non‐forward‐moving)
individuals
(
p
0.05).
those
marked
increase
corresponding
reduction
noted
Human
elevated
compared
However,
vesicle
SD
differ
Control
Obesity
groups
Distinct
profiles
stratified
BMI,
exhibit
impacts
quality.
Low‐dose
under
physiological
conditions,
maintains
integrity
augments
fertilization
potential.
administration
demonstrates
superior
effectiveness
parameters,
particularly